United States · FDA National Drug Code directory
Neostigmine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-528_649d8760-81df-13da-6556-14a0fdbc8b02
- Product NDC
- 43598-528
- Form
- INJECTION
- Composition / generic term
- Neostigmine
- Labeler
- Dr.Reddy's Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180904
- Source listing expiry
- 20261231
Source-listed ingredients
- NEOSTIGMINE METHYLSULFATE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (43598-528-11) / 10 mL in 1 VIAL, MULTI-DOSE · 43598-528-11
- 10 VIAL, MULTI-DOSE in 1 CARTON (43598-528-36) / 10 mL in 1 VIAL, MULTI-DOSE · 43598-528-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →